Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis. Ronnacker J, Muller PJ, Mikesch JH, Zukunft S, et al. Leukemia 2025;39:2174-2180.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ronnacker J, Muller PJ, Mikesch JH, Zukunft S, et al. Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis. Leukemia 2025;39:2174-2180.
PMID: 40691504